Skip to main content

Vaccine surge, commodity price curbs

After a slow start, China’s COVID-19 vaccine rollout is now one of the world’s fastest and is currently responsible for over half of daily inoculations globally. At this pace, China could catch up with the developed world within a quarter or two and achieve herd immunity by year-end. This should support a further rebound in the service sector, which even in China is still being held back by the pandemic. Meanwhile, the State Council has called for further efforts to cap rising commodity prices. But with capacity already stretched and few signs of speculative activity, administrative tools will be of limited use. A drop in demand may do the job instead, as the withdrawal of last year’s stimulus weighs on construction activity.

Become a client to read more

This is premium content that requires an active Capital Economics subscription to view.

Already have an account?

You may already have access to this premium content as part of a paid subscription.

Sign in to read the content in full or get details of how you can access it

Register for free

Sign up for a free account to gain:

  • Unlock additional content
  • Register for Capital Economics events
  • Receive email updates and economist-curated newsletters
  • Request a free trial of our services

Get access